Oxfam Files SEC Complaint Against Moderna for Deceiving Investors Over Patent Dispute

"Instead of being transparent and using its life-saving technology to help curb the pandemic," said Oxfam America's Diana Kearney, "Moderna is doing the opposite, obfuscating its patent dispute with the U.S. government."